Patent details

EP3969449 Title: NEW CRYSTALLINE FORMS OF N-(3-(2-(2-HYDROXYETHOXY)-6-MORPHOLINOPYRIDIN-4-YL)-4-METHVLPHENYL)-2(TRIFLUOROMETHYL)ISONICOTINAMIDE AS RAF INHIBITORS FOR THE TREATMENT OF CANCER

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3969449
WO Application Number:
IB2020054491
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP20726561.2
WO Publication Number:
WO2020230028
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
12/05/2020
Grant date:
12/02/2025
EP Publication Date:
23/03/2022
WO Publication Date:
19/11/2020
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
12/02/2025
EP B1 Publication Date:
12/02/2025
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
11/05/2040
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
12/02/2025
 
 

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, BASEL, Switzerland (CH)

Inventor

1

Name:
HARLACHER, Cornelius Stephen
Address:
4002 Basel, Switzerland (CH)

2

Name:
LI, Zaixing
Address:
Shanghai 201203, China (CN)

3

Name:
WAYKOLE, Liladhar Murlidhar
Address:
Succasunna, New Jersey 07876, United States of America (US)

Priority

Priority Patent Number:
PCT/CN2019/086595
Priority Date:
13/05/2019
Priority Country:
World Intellectual Property Office (WIPO) (WO)

Classification

IPC or IDT classification:
C07D 413/14; A61P 35/00; A61K 31/5375;

Publication

Bulletin

Bulletin Heading:
EP2
Journal edition number:
07/25
Publication date:
12/02/2025
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202512
Publication date:
19/03/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
202507
Publication date:
12/02/2025
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
31/05/2025
Annual Fee Number:
6
Annual Fee Amount:
160 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type